Pacira BioSciences, Inc.PCRXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.4%
5Y CAGR+14.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+11.4%/yr
vs +11.1%/yr prior
5Y CAGR
+14.6%/yr
Recent deceleration
Acceleration
+0.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $117.31M | +43.8% |
| 2024 | $81.58M | +7.0% |
| 2023 | $76.26M | -10.1% |
| 2022 | $84.80M | +52.7% |
| 2021 | $55.55M | -6.5% |
| 2020 | $59.42M | -17.6% |
| 2019 | $72.12M | +29.5% |
| 2018 | $55.69M | -2.8% |
| 2017 | $57.29M | +25.4% |
| 2016 | $45.68M | - |